Voluven
Sponsors
Biopure Corporation, Rigshospitalet, Denmark, University of Saskatchewan, NYU Langone Health, Assiut University
Conditions
Angina PectorisAortic Valve DiseaseArthroplasty, HipBrain EdemaCoronary Artery DiseaseHypotension Drug-InducedIntracranial AneurysmMitral Valve Disease
Early Phase 1
Phase 2
Unknown Phase
Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty
TerminatedNCT01452581
Start: 2011-10-31End: 2012-09-30Updated: 2015-03-06
Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%
WithdrawnNCT01849757
Start: 2013-11-30End: 2017-11-30Updated: 2019-05-03
Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients
CompletedNCT02701582
Start: 2014-03-31End: 2016-09-30Updated: 2019-08-28
Effect of Hydroxyethyl Starch (Voluven 130/0.4) on Bloof Glucose Levels during Othtopaedic Lower Limb Surgery Under Spinal Anaesthesia
Active, not recruitingPACTR201710002591405
Start: 2017-09-25Target: 140Updated: 2026-01-27